2014

Boston Scientific to Participate in the Citi 2013 Global Healthcare Conference

NATICK, Mass., Feb. 20, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Citi 2013 Global Healthcare Conference on February 25 in New York.

Executive Vice President and Chief Financial Officer Jeff Capello will participate in a 20-minute presentation followed by a 20-minute question and answer session regarding the company beginning at approximately 11:05 a.m. ET.

A live webcast of the presentation and question and answer session will be available on the Investor Relations section of the Boston Scientific website at www.bostonscientific.com/investors.  Interested parties are encouraged to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.

This webcast is being hosted by Citi.  A replay will be archived and available at www.bostonscientific.com/investors beginning approximately one hour following the completion of the question and answer session.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.  For more information, visit us at www.bostonscientific.com.

CONTACT:   
Steven Campanini
508-652-5740 (office)
Media Relations
Boston Scientific Corporation
media@bsci.com

Michael Campbell
508-650-8023 (office)
Investor Relations
Boston Scientific Corporation
investor_relations@bsci.com

 

SOURCE Boston Scientific Corporation



RELATED LINKS
http://www.bostonscientific.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.